Anne Calvaresi
Family · Philadelphia, PANPI 1306106513
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $53,363 of the $81,028 with a category attached, or 65.9%. 16 manufacturers reported payments, led by Johnson & Johnson at 56.4% of the total. Reporting peaked in 2022 at $39,352 and has fallen 99.7% since, to $124 in 2025. Among family clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 156 payments — averaging $519.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$46K
- Tolmar Pharmaceuticals, Inc.$21K
- Merck$9K
- Photocure Inc$4K
- Pfizer$900
- C. R. Bard, Inc. & Subsidiaries$158
- plus $515 from 10 others
What the payments were for
- Consulting fees$9,11711%
- Speaking & faculty fees$53,36366%
- Travel & lodging$15,44719%
- Food & beverage$3,0934%
- Education$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 83 | $45,663 |
| Tolmar Pharmaceuticals, Inc. | 32 | $20,873 |
| Merck | 16 | $9,346 |
| Photocure Inc | 5 | $3,572 |
| Pfizer | 1 | $900 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $158 |
| Dentsply IH AB | 5 | $119 |
| Rochester Medical Corporation | 2 | $102 |
| 180 Medical, Inc. | 1 | $90 |
| Telix Pharmaceuticals | 3 | $72 |
| Dentsply IH Inc. | 1 | $41 |
| Janssen Scientific Affairs, LLC | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $15 |
| AstraZeneca | 1 | $14 |
| Coloplast | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$81,028 in reported general payments places this provider in the 95th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 41 | $705 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $369 |
| Finasteride | 15 | $210 |
Paid to pharmacies, not to this prescriber.
Other family in Philadelphia
- Bethany ThomasPhiladelphia$126K
- Bethany MooneyPhiladelphia$73K
- Susan Estrella-EadesPhiladelphia$61K
- Michelle Vega-OlivoPhiladelphia$55K
- Danielle LandPhiladelphia$48K
- Nicole SmithPhiladelphia$37K
- Dana SerafinPhiladelphia$31K
- Tammaris KaschakPhiladelphia$27K
- Laura NoltePhiladelphia$21K
- Christopher RenziPhiladelphia$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.